ABSTRACT
INTRODUCTION

53
The concept that probiotics are beneficial to gut health has been investigated for a number of years.
54
Studies have demonstrated that probiotics improve gut function potentially through a number of 55 mechanisms (46) including increasing epithelial barrier function (13) and modulation of the immune 56 response (21). There is also evidence that probiotics can prevent colonisation of the gut by pathogens.
57
This can be via mechanisms such as down regulation of virulence factors and inhibition of pathogen 58 adherence to the epithelium (6, 9, 15) . For example, Lactobacillus species inhibit the adhesion of
59
Enterobacter sakazakii to intestinal mucus by competitive exclusion (9, 10) . Other studies demonstrated 60 that some probiotics increase the production of intestinal mucin thus inhibiting pathogen adherence to 61 intestinal epithelial cells (34) . Probiotics are also able to produce antimicrobial peptides (bacteriocins) 62 and acids. Collectively, there are numerous probiotic mediated mechanisms that limit pathogen 63 colonisation (39, 44, 46) . showed that this bacterium lowered the incidence of post-surgical infection (42). Currently, research is 68 also investigating the topical use of probiotics to augment the skin barrier function to promote skin 69 health or prevent or treat disease (8, 15, 16, 18, 50) . The benefits of topical application of probiotics are 70 still speculative and researchers are now focussing on this area to improve conditions such as excessive 71 skin sensitivity, atopic dermatitis, psoriasis or to stimulate the wound healing process (3, 8, 12, 52) .
72
However, an important consideration will be the safety of using live bacteria especially in situations 
MATERIALS AND METHODS
103
Mammalian cell culture
104
Normal human epidermal keratinocytes (NHEK) cultured in keratinocyte basal medium (Promocell, 105 Heidelberg, Germany) containing a supplement mix (bovine pituitary extract 0.004mg/ml, epidermal 106 growth factor (recombinant-human) 0.125ng/ml, insulin (recombinant human) 5µg/ml, hydrocortisone 107 0.33µg/ml, epinephrine 0.39µg/ml and transferrin, holo (human) 10µg/ml) and 0.06mM CaCl 2
108
(Promocell, Heidelberg, Germany), were used as a model system. These were cultured routinely at 37 o C 109 in a humid atmosphere of 5% CO 2 in T-75 culture flasks as described previously (40). Figure 1B ). This is in 194 contrast to the effects observed with L. reuteri which we showed previously to be protective to pathogen P=0.004, Figure 2A ). In 'post-exposure' experiments, keratinocytes were exposed to S. aureus for 2h, 
214
We investigated whether the probiotic lysate had direct effects on the growth of the pathogen by 215 growing them simultaneously in culture. Competition assays showed a significant reduction in S.
216
aureus growth over a period of 24 h in the presence of 100µl of L. rhamnosus GG lysate compared to 217 untreated cultures (P=0.02, Figure 3A ). This effect was specific to the lysate because the spent culture 218 fluid from L. rhamnosus GG had no effect on the growth of S. aureus ( Figure 3B ). Furthermore, the 219 ability of the lysate to inhibit pathogenic growth was negated by heating the lysate to 100 o C for 10 min
220
( Figure 3C ), Finally, this direct effect of L. rhamnosus GG on pathogenic growth appeared to be 221 species specific because the lysate from L. reuteri, made in exactly the same way had no effect on the 222 growth of S. aureus ( Figure 3D ).
223
We counted the numbers of viable staphylococci following 24h incubation with keratinocytes in the 224 presence or absence of the L. rhamnosus GG lysate. When S. aureus was added to keratinocytes at the 225 same time as the L. rhamnosus GG lysate, the total number of viable staphylococci was also 226 significantly reduced to 5 log 10 cfu/ml, (compared to 8 log 10 cfu/ml for S. aureus alone, P=0.02 Figure   227 5). Furthermore, when the L. rhamnosus GG lysate was added 12h post infection of the keratinocytes,
228
a reduction in number of viable S. aureus was observed when these were counted 24h later ( Figure   229 4).These effects were not seen with either the spent culture fluid from L. rhamnosus GG nor a lysate 230 from L. reuteri (data not shown). Since lactobacilli can produce organic acids, we measured the pH of 231 keratinocyte media infected for 24h with S. aureus, L. rhamnosus GG lysate or both simultaneously.
232
However, there was no significant difference in the pH between treatments group (data not shown).
233
We also measured the pH of lysate alone and found it be pH= 7.2 thus suggesting that acid mediated 234 effects were not likely to be the mechanism underlying inhibition of pathogenic growth. The 235 antimicrobial properties of L. rhamnosus GG and lysate were evaluated using a spot-on-lawn assay.
236
This assay showed significant inhibition of S. aureus growth (as evidenced by the presence of zones of 237 inhibition) by anaerobic live cultures or lysates of L. rhamnosus GG grown anaerobically (Table 1) . By 238 contrast, live L. reuteri or lysate did not induce zones of inhibition in this assay (Table 1) .
240
L. rhamnosus GG inhibits adhesion of S. aureus to keratinocytes. 241
Another mechanism by which live bacteria, lysate or spent culture fluid of L. rhamnosus GG may 242 protect the keratinocytes is by inhibition of pathogenic adhesion. Previously, we showed that agents that 243 reduce adhesion of S. aureus to keratinocytes also reduce its toxicity (40). Hence, we considered that 244 inhibition of adhesion may also be part of the protective mechanism of L. rhamnosus GG, lysate or spent 245 culture fluid. Adhesion assays were performed to determine whether inhibition was due to competition, Figure 5D ). However, the spent culture fluid did not reduce S. aureus adhesion. The current investigation suggests that there are at least two, possibly separate activities involved in the 269 protective effects of L. rhamnosus GG. These are likely to be inhibition of pathogen adhesion and 270 inhibition of pathogen growth. We showed previously that agents that reduce adhesion of S. aureus to 271 keratinocytes also reduce its toxicity in our viability assay (40). In keeping with this, the ability of the faecalis by excluding and displacing them from the cell-binding sites (30, 39, 41 there was no effect of L.rhamnosus GG spent culture fluid on the viability of S. aureus. However, again, of L. rhamnosus GG. Indeed, the lysate from this organism was neutral (pH 7.2) but was still able to 323 inhibit S. aureus growth. Furthermore, neither L. reuteri nor L. salivarius showed any inhibitory activity 324 on the growth of S. aureus even though both these bacteria are also able to produce acid (5, 14).
325
In conclusion, we have shown that L. rhamnosus GG uses multiple mechanisms to protect keratinocytes 326 from S. aureus. These include exclusion of pathogens, inhibition of pathogen growth and displacement 327 of pathogen from keratinocytes. Of course, it is possible that this displacement activity may be related 328 to the ability of L. rhamnosus GG to inhibit growth and further studies will be required to clarify this 329 point. A number of studies has suggested the utility of probiotic species of lactobacilli for use topically.
330
In keeping with these studies, we suggest that L. rhamnosus GG is a potential new agent to inhibit the 331 pathogenicity of S. aureus to keratinocytes. Furthermore, our data shows that the utility of L. rhamnosus 332 GG on skin will not be limited by whether it can grow and survive on skin because a lysate of the 333 14 organisms is just as efficacious at preventing S. aureus colonization as live bacteria. We suggest that the 334 use of bacterial lysates will enhance the utility of lactobacilli since the need to produce formulations that 335 maintain bacterial viability is negated. Furthermore, lysates potentially offer a safer option than live 336 bacteria for treatment of damaged skin. 19. Gueniche, A., David, P., Achachi, A., Vocanson, M., Buyukpamukcu, A., Bastien, P., 28. Kinoshita H., Uchida H., Kawai Y., Kitazawa H., Miura K., Shiiba K., Horii A., Saito T. for dental health. Food Science and Technology Bulletin: Functional Foods, 6, 37. Morita H., Toh H., Fukuda S., Horikawa H., Oshima K., Suzuki T., Murakami M., Pharmacy and Pharmacology, 5, 2395-2401. 475 39. Ohnemus, U., Kohrmeyer, K., Houdek, P., Rohde, H., Wladykowski, E., Vidal, S., staphylococci. The number of viable S. aureus (SA) was 8log CFU/ml, whereas 5 log CFU/ml of S. 591 aureus (SA) were viable in the present of L. rhamnosus GG lysate (Co-exposed). Additionally, the total 592 number of viable staphylococci in keratinocyte culture was reduced by the L. rhamnosus GG lysate 593 when this was added 2-4-6-8 and 12 hours after infection of the keratinocytes with pathogen (Post- 
